{"id":28,"date":"2024-04-23T10:10:38","date_gmt":"2024-04-23T08:10:38","guid":{"rendered":"https:\/\/urbinocamdlab.wordpress.com\/?page_id=28"},"modified":"2026-09-01T09:36:08","modified_gmt":"2026-09-01T09:36:08","slug":"team","status":"publish","type":"page","link":"https:\/\/camd.uniurb.it\/?page_id=28","title":{"rendered":"The Team"},"content":{"rendered":"\n

Current Members<\/h2>\n\n\n\n
\n
\n
\"Giovanni<\/figure>\n<\/div>\n\n\n\n
\n

Giovanni Bottegoni<\/strong><\/p>\n\n\n\n

Giovanni Bottegoni is Professor of Medicinal Chemistry at the Department of Biomolecular Sciences of the University of Urbino and Honorary Senior Research Fellow at the University of Birmingham. Following his PhD at the University of Bologna and postdoctoral research at Scripps Research Institute (La Jolla, USA), he held roles at the Italian Institute of Technology (Genova, Italy), BiKi Technologies (Genova, Italy) and Heptares Therapeutics (now Nxera, Cambridge, UK). His research focuses on computer-assisted molecular design and computational medicinal chemistry. He is a Fellow of the Royal Society of Chemistry and a member of the Board of Directors of the QSAR, Chemoinformatics and Modeling Society<\/a>. He obtained a Master in International Healthcare Management, Economics and Policy (MIHMEP) from SDA Bocconi (Milan, Italy) and a Certificate of Advanced Studies in Management of Biotech, Medtech and Pharma Ventures from EPFL (Lausanne, Switzerland). In 2015, he was awarded the DCF Prize by the Medicinal Chemistry Division of the Italian Chemical Society. In 2018, he was the most meritorious runner-up for the EFMC Prize for a Young Medicinal Chemist or Chemical Biologist in Industry.<\/p><\/p>\n\n\n\n

LinkedIn<\/a> \u00b7 ORCID<\/a><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\"Mattia<\/figure>\n<\/div>\n\n\n\n
\n

Mattia Bernetti<\/strong><\/p>\n\n\n\n

Mattia Bernetti is Assistant Professor (RTD-B) at the Department of Biomolecular Sciences of the University of Urbino. He obtained his PhD in Biotechnological and Pharmaceutical Sciences from the University of Bologna in 2018, including a research period at the University of California San Diego. He subsequently conducted postdoctoral research at SISSA in Trieste and at the Italian Institute of Technology in Genoa. His research applies computational methods, particularly molecular dynamics simulations, to investigate the structure and dynamics of pharmaceutically relevant biomolecules, including non-coding RNAs. In 2026, he was awarded the DCF Prize by the Medicinal Chemistry Division of the Italian Chemical Society.<\/p><\/p>\n\n\n\n

LinkedIn<\/a> \u00b7 ORCID<\/a><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n

Gian Marco Elisi<\/strong><\/p>\n\n\n\n

Gian Marco Elisi is a Postdoctoral Researcher (RTD-A) and Lecturer in Medicinal Chemistry at the University of Urbino, where he also contributes to the VITALITY project<\/a> related to the development of a platform for preclinical drug discovery. He obtained his PhD in Drug Sciences from the University of Parma in 2023, including a research secondment at the University of Geneva, and later worked at Evotec as a Senior Scientist. His research focuses on computational medicinal chemistry, particularly free-energy simulations and virtual-screening approaches with a focus on multi-target compounds.<\/p><\/p>\n\n\n\n

LinkedIn<\/a> \u00b7 ORCID<\/a><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\"Lara<\/figure>\n<\/div>\n\n\n\n
\n

Lara Davani<\/strong><\/p>\n\n\n\n

Lara Davani is a Postdoctoral Researcher at the University of Urbino. Her research focuses on the development and application of advanced analytical and biophysical methods to support drug discovery and characterise ligand\u2013target interactions. She obtained her PhD from the University of Bologna in 2022, including a research period at the University of T\u00fcbingen. Before joining CAMD, she held postdoctoral positions at the University of Bologna and the University of Milan, working on analytical-method development and quantitative proteomics.<\/p><\/p>\n\n\n\n

LinkedIn<\/a> \u00b7 ORCID<\/a><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\"Matilda<\/figure>\n<\/div>\n\n\n\n
\n

Matilda Ymeraj<\/strong><\/p>\n\n\n\n

Matilda Ymeraj is a PhD student in the Computer-Assisted Molecular Design Lab under the supervision of Professor Giovanni Bottegoni. She graduated in Pharmaceutical Chemistry and Technology from the University of Urbino \u201cCarlo Bo\u201d in 2023. Her doctoral research applies computational chemistry to pharmaceutically relevant molecular systems, with particular expertise in hybrid quantum mechanics\/molecular mechanics (QM\/MM) simulations developed through a research secondment at the University of Bristol.<\/p><\/p>\n\n\n\n

LinkedIn<\/a> \u00b7 ORCID<\/a><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\"Sabrina<\/figure>\n<\/div>\n\n\n\n
\n

Sabrina Papi<\/strong><\/p>\n\n\n\n

Sabrina Papi is a Research Fellow at the University of Urbino. She graduated in Pharmacy from the University of Urbino in 2025, completing her dissertation research in the CAMD Lab. She subsequently joined the lab as a Research Fellow, where she applies enhanced-sampling methods to investigate conformational transitions in a target family of medicinal-chemistry interest, in collaboration with an industrial partner.<\/p><\/p>\n\n\n\n

LinkedIn<\/a> \u00b7 ORCID<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n\n\n\n

<\/p>\n\n\n\n

Alumni<\/h2>\n\n\n\n

Our alumni have played an essential role in shaping CAMD and in making much of our current work possible. Their ideas, commitment and contributions remain part of the foundations on which the lab continues to build.<\/p><\/p>\n\n\n\n

\u201cThe road goes ever on and on.\u201d<\/em> J.R.R. Tolkien, The Lord of the Rings<\/em><\/p>\n\n\n\n

<\/div>\n\n\n\n
\n
\n
\"Federico<\/figure>\n\n\n\n

Federico Ricci<\/strong>
Postdoctoral Fellow, 2023\u20132026<\/em><\/p>\n\n\n\n

Federico worked on the identification of multitarget compounds for multiple sclerosis through the MARs research grant funded by the Italian Multiple Sclerosis Foundation (FISM).<\/p><\/p>\n\n\n\n

LinkedIn<\/a> \u00b7 ORCID<\/p>\n<\/div>\n\n\n\n

\n
\"Adriana<\/figure>\n\n\n\n

Adriana Coricello<\/strong>
Postdoctoral Fellow, 2022\u20132025<\/em><\/p>\n\n\n\n

Adriana worked on computational medicinal chemistry and multitarget agents. In 2025, she was awarded a Fondazione Umberto Veronesi Postdoctoral Fellowship.<\/p><\/p>\n\n\n\n

LinkedIn<\/a> \u00b7 ORCID<\/a><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\"Sonja<\/figure>\n\n\n\n

Sonja Peter<\/strong>
PhD Student, Cycle XXXVIII, 2023\u20132025<\/em><\/p>\n\n\n\n

Sonja conducted her doctoral research in an industrial setting within the EU-funded ALLODD<\/a> doctoral training network, applying computational approaches to drug discovery.<\/p><\/p>\n\n\n\n

LinkedIn<\/a> \u00b7 ORCID<\/a><\/p>\n<\/div>\n\n\n\n

\n
\"David<\/figure>\n\n\n\n

David Sotillo N\u00fa\u00f1ez<\/strong>
PhD Student, Cycle XXXVIII, 2023\u20132025<\/em><\/p>\n\n\n\n

David conducted his doctoral research within the EU-funded ALLODD<\/a> doctoral training network, applying computational methods to the investigation of allosteric drug discovery.<\/p><\/p>\n\n\n\n

LinkedIn<\/a> \u00b7 ORCID<\/a><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\"Vittorio<\/figure>\n\n\n\n

Vittorio Lembo<\/strong>
PhD Student, Cycle XXXVIII, 2023\u20132025<\/em><\/p>\n\n\n\n

Vittorio conducted his doctoral research in the CAMD Lab under the supervision of Professor Giovanni Bottegoni, with funding from the Italian Institute of Technology (IIT).<\/p><\/p>\n\n\n\n

LinkedIn<\/a> \u00b7 ORCID<\/a><\/p>\n<\/div>\n\n\n\n

\n
\"Dominga<\/figure>\n\n\n\n

Dominga Evangelista<\/strong>
Visiting PhD Student, Cycle XXXVII, 2022\u20132024<\/em><\/p>\n\n\n\n

Dominga joined CAMD as a visiting doctoral student from the University of Bologna, where her PhD research was jointly supervised by Professor Giovanni Bottegoni and Professor Marinella Roberti.<\/p><\/p>\n\n\n\n

LinkedIn<\/a> \u00b7 ORCID<\/a><\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Current Members Giovanni Bottegoni Giovanni Bottegoni is Professor of Medicinal Chemistry at the Department of Biomolecular Sciences of the University of Urbino and Honorary Senior Research Fellow at the University of Birmingham. Following his PhD at the University of Bologna and postdoctoral research at Scripps Research Institute (La Jolla, USA), he held roles at the […]<\/p>\n","protected":false},"author":6,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","footnotes":""},"class_list":["post-28","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/camd.uniurb.it\/index.php?rest_route=\/wp\/v2\/pages\/28","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/camd.uniurb.it\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/camd.uniurb.it\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/camd.uniurb.it\/index.php?rest_route=\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/camd.uniurb.it\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=28"}],"version-history":[{"count":37,"href":"https:\/\/camd.uniurb.it\/index.php?rest_route=\/wp\/v2\/pages\/28\/revisions"}],"predecessor-version":[{"id":363,"href":"https:\/\/camd.uniurb.it\/index.php?rest_route=\/wp\/v2\/pages\/28\/revisions\/363"}],"wp:attachment":[{"href":"https:\/\/camd.uniurb.it\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=28"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}